NYB (NYB Holdings) ROE % Adjusted to Book Value: Negative Equity% (As of Sep. 2025)


What is NYB Holdings ROE % Adjusted to Book Value?

NYB Holdings NYB ROE % Adjusted to Book Value is Negative Equity% as of Sep. 2025.

NYB Holdings's ROE % for the quarter that ended in Sep. 2025 was Negative Equity. NYB Holdings's PB Ratio for the quarter that ended in Sep. 2025 was N/A. NYB Holdings's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2025 was Negative Equity.

NYB Holdings ROE % Adjusted to Book Value Related Terms

NYB Holdings ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for NYB Holdings's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NYB Holdings ROE % Adjusted to Book Value Chart

NYB Holdings Annual Data
Trend Sep24 Sep25
ROE % Adjusted to Book Value
0.00 Negative Equity

NYB Holdings Semi-Annual Data
Sep24 Sep25
ROE % Adjusted to Book Value 0.00 Negative Equity

NYB vs : ROE % Adjusted to Book Value Comparison

For the Biotechnology subindustry, NYB Holdings's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

NYB Holdings ROE % Adjusted to Book Value vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, NYB Holdings's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where NYB Holdings's ROE % Adjusted to Book Value falls into.


NYB Holdings ROE % Adjusted to Book Value Calculation

NYB Holdings's ROE % Adjusted to Book Value for the fiscal year that ended in Sep. 2025 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=Negative Equity / N/A
=Negative Equity

NYB Holdings's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2025 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=Negative Equity / N/A
=Negative Equity

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROE % Adjusted to Book Value of Negative Equity% mean?
NYB Holdings (NYB) has a ROE % Adjusted to Book Value of Negative Equity% as of Sep. 2025. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on NYB Holdings and its competitors.
Is NYB Holdings' ROE % Adjusted to Book Value too high?
NYB Holdings' current ROE % Adjusted to Book Value is Negative Equity%.
How does NYB Holdings' ROE % Adjusted to Book Value compare to ?
NYB Holdings' ROE % Adjusted to Book Value of Negative Equity% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Biotechnology company?
A good ROE % Adjusted to Book Value depends on the Biotechnology industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on NYB Holdings and its competitors. NYB Holdings's current ROE % Adjusted to Book Value is Negative Equity%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NYB Holdings stock overvalued right now?
NYB Holdings (NYB) has a current ROE % Adjusted to Book Value of Negative Equity%. The current ROE % Adjusted to Book Value is Negative Equity%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For NYB Holdings (NYB), the current ROE % Adjusted to Book Value is Negative Equity% as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

NYB Holdings Business Description

Comparable Companies
Address 456 Alexandra Road, No. 04-07, Fragrance Empire Building, Singapore, SGP, 119962
NYB Holdings Ltd, along with its subsidiaries, is a pre-clinical biopharmaceutical company engaged in the research and development of therapeutics and nutraceuticals derived from biodiversity, including tropical medicinal plants with a history of traditional use. It focuses on discovering and developing natural compounds for applications in oncology and other chronic diseases, and also offers a consumer nutraceutical product line.